Editas Medicine Inc (EDIT)

08:57 AM

What drives Editas Medicine Inc. stock priceTriple-digit profit margins - PrintWeekIndia

08:57 AM

04:53 AM

Will Editas Medicine Inc. stock split in the near futureConsistent triple-digit returns - jammulinksnews.com

04:53 AM

01:30 AM

Can Editas Medicine Inc. stock recover from recent declineFree Stock Market Forecast Reports - jammulinksnews.com

01:30 AM

Jul 23, 2025

What analysts say about Editas Medicine Inc. stockBreakout stock performance - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Editas Medicine Inc. Stock Analysis and ForecastUnrivaled growth potential - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Editas Medicine Inc. a good long term investmentExceptional profit margins - Autocar Professional

Jul 22, 2025

Jul 22, 2025

There's Reason For Concern Over Editas Medicine, Inc.'s (NASDAQ:EDIT) Massive 42% Price Jump - simplywall.st

Jul 22, 2025

Jul 19, 2025

What makes Editas Medicine Inc. stock price move sharplyVerified Return Tips - beatles.ru

Jul 19, 2025

Jul 15, 2025

Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Rating of "Hold" from Brokerages - MarketBeat

Jul 15, 2025

Jul 14, 2025

Numerous Editas Medicine Insiders Sold Stock: Not A Positive Omen - simplywall.st

Jul 14, 2025

Jul 10, 2025

Crispr Genomic Cure Market in 2032: A Glimpse Into the Future - openPR.com

Jul 10, 2025

Jul 09, 2025

Editas Medicine (EDIT) Soars 7.69% on Positive Data - AInvest

Jul 09, 2025

Jul 08, 2025

Cathie Wood shells out $13.9 million for one high-stakes biotech stock - Yahoo Finance

Jul 08, 2025

Jul 08, 2025

Editas Surpasses Therapeutic Gene Editing Threshold in New Preclinical Data - MSN

Jul 08, 2025

Jul 02, 2025

Restore Health – Therapies that cureTelethon - Ricerca Malattie Genetiche Rare

Jul 02, 2025

Jun 30, 2025

Editas Medicine, Inc.(NasdaqGS: EDIT) added to Russell 3000E Index - MarketScreener

Jun 30, 2025

Jun 30, 2025

Top 10 CRISPR Stocks to Buy Now - Insider Monkey

Jun 30, 2025

Jun 28, 2025

Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now? - The Motley Fool

Jun 28, 2025

Jun 27, 2025

2 Beaten-Down Stocks to Avoid - The Globe and Mail

Jun 27, 2025

Jun 25, 2025

Gene Editing Market Set to Witness Significant Growth by 2025-2032 | CRISPR Therapeutics, Editas Medicine - openPR.com

Jun 25, 2025

Jun 20, 2025

Gene editing stocks gain amid FDA's latest leadership change (EDIT:NASDAQ) - Seeking Alpha

Jun 20, 2025

Jun 19, 2025

Cancer Gene Therapy Market Set to Soar: Breakthrough - openPR.com

Jun 19, 2025

Jun 18, 2025

From Now to 2032: Unpacking the Genome Editing Market's - openPR.com

Jun 18, 2025

Jun 18, 2025

Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst - Benzinga

Jun 18, 2025

Jun 17, 2025

Editas Medicine Is Great. Here's Why You Shouldn't Buy It. - AOL.com

Jun 17, 2025

Jun 17, 2025

Editas Medicine Is Great. Here's Why You Shouldn't Buy It. - The Motley Fool

Jun 17, 2025

Jun 17, 2025

Analysts Set Editas Medicine, Inc. (NASDAQ:EDIT) Price Target at $5.36 - MarketBeat

Jun 17, 2025

Jun 14, 2025

Editas Medicine, Inc. (NASDAQ:EDIT) Position Trimmed by Bank of America Corp DE - MarketBeat

Jun 14, 2025

Jun 14, 2025

Analysts Offer Predictions for Editas Medicine FY2026 Earnings - MarketBeat

Jun 14, 2025

Jun 13, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Holdings in Editas Medicine, Inc. (NASDAQ:EDIT) - MarketBeat

Jun 13, 2025

Jun 12, 2025

Editas Medicine (EDIT) Unveils Promising Gene Editing Data for B - GuruFocus

Jun 12, 2025